Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voclosporin in adolescents with lupus nephritis
2020-005807-37Phase 3Active
- Sponsor
- Aurinia
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in lupus nephritis (LN) comparing Voclosporin with Placebo (2 arms). Primary endpoint: Renal response at Week 24. Started Jan 2022; status: active.
02
Drugs
voclosporin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on 2020-005807-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005807-37.